Today: 3 July 2026
Browse Category

LSE:FUTR 4 December 2025 - 22 January 2026

Future plc snaps up SheerLuxe for £39.9m as buyback rolls on and Fidelity lifts stake

Future plc snaps up SheerLuxe for £39.9m as buyback rolls on and Fidelity lifts stake

Future announced Thursday it will acquire UK digital publisher SheerLuxe, along with BLUSH Talent MGMT, for an initial £39.9 million in cash. Shares jumped 3.7% to 525.5 pence by 0835 GMT, per Fidelity data. The timing of the deal is tricky for Future, coming after a steep decline in its stock price. Shares have fallen over 40% in the last year and are hovering close to their 52-week lows, per data from Investing.com.
22 January 2026
Future plc (FUTR) Hikes Dividend Fivefold and Launches New Buyback After Tough 2025 – Analysts Still See Big Upside

Future plc (FUTR) Hikes Dividend Fivefold and Launches New Buyback After Tough 2025 – Analysts Still See Big Upside

Future plc, the UK-based specialist media and Go.Compare owner, has reported a drop in revenue and profit for the year to 30 September 2025 – but paired the weaker headline numbers with aggressive shareholder returns, a confident outlook for 2026 and a sizeable valuation gap versus analysts’ price targets. MarketScreener+2Shares Magazine+2 On 4 December 2025, the group unveiled full-year results, a fivefold dividend increase, a fresh £30 million share buyback and a board succession plan, triggering a sharp rebound in the share price from depressed levels.
4 December 2025
··

Stock Market Today

  • Proteomics International (ASX: PIQ) Soars 28% on Friday as Investors React to Regulatory and Commercial Moves
    July 3, 2026, 12:16 AM EDT. Shares of Proteomics International Laboratories Ltd (ASX: PIQ) shot up 28.13% to AUD 0.20 on Friday after the company announced steps forward in its precision diagnostics and proteomics technology platform. The move comes as PIQ works on expanding its commercial footprint, securing regulatory clearances, and building up globally. The company said it's working to grow product adoption through new partnerships and continued research. Main push comes from recent regulatory progress, wider distribution, and more money going into new projects. But the company still faces regulatory risk, rivals, funding questions, and tough broader markets as a small-cap. Investors are tracking news on commercial deals and the next round of regulatory news that could move the stock again.
Go toTop